[HTML][HTML] Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
The COVID-19 pandemic is an extraordinary global emergency that has led to the
implementation of unprecedented measures in order to stem the spread of the infection …
implementation of unprecedented measures in order to stem the spread of the infection …
[HTML][HTML] Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
B Sun, L Wu, Y Wu, C Zhang, L Qin… - Frontiers in …, 2020 - frontiersin.org
Centella asiatica (also known as Centella asiatica (L.) Urb. or Gotu kola) is a traditional
Chinese medicine with extensive medicinal value, which is commonly used in Southeast …
Chinese medicine with extensive medicinal value, which is commonly used in Southeast …
[HTML][HTML] The protective role of butyrate against obesity and obesity-related diseases
S Coppola, C Avagliano, A Calignano, R Berni Canani - Molecules, 2021 - mdpi.com
Worldwide obesity is a public health concern that has reached pandemic levels. Obesity is
the major predisposing factor to comorbidities, including type 2 diabetes, cardiovascular …
the major predisposing factor to comorbidities, including type 2 diabetes, cardiovascular …
The multifaceted role of fibrinogen in tissue injury and inflammation
JP Luyendyk, JG Schoenecker… - Blood, The Journal of the …, 2019 - ashpublications.org
The canonical role of the hemostatic and fibrinolytic systems is to maintain vascular integrity.
Perturbations in either system can prompt primary pathological end points of hemorrhage or …
Perturbations in either system can prompt primary pathological end points of hemorrhage or …
[HTML][HTML] Review of synthetic and hybrid scaffolds in cartilage tissue engineering
M Wasyłeczko, W Sikorska, A Chwojnowski - Membranes, 2020 - mdpi.com
Cartilage tissue is under extensive investigation in tissue engineering and regenerative
medicine studies because of its limited regenerative potential. Currently, many scaffolds are …
medicine studies because of its limited regenerative potential. Currently, many scaffolds are …
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
G Livshits, A Kalinkovich - Ageing research reviews, 2019 - Elsevier
Sarcopenia, obesity and their coexistence, obese sarcopenia (OBSP) as well as
atherosclerosis-related cardio-vascular diseases (ACVDs), including chronic heart failure …
atherosclerosis-related cardio-vascular diseases (ACVDs), including chronic heart failure …
Adipose tissue is a critical regulator of osteoarthritis
KH Collins, KL Lenz, EN Pollitt… - Proceedings of the …, 2021 - National Acad Sciences
Osteoarthritis (OA), the leading cause of pain and disability worldwide, disproportionally
affects individuals with obesity. The mechanisms by which obesity leads to the onset and …
affects individuals with obesity. The mechanisms by which obesity leads to the onset and …
Obesity and kidney disease
JI Lakkis, MR Weir - Progress in cardiovascular diseases, 2018 - Elsevier
Obesity is a systemic disease of the white adipose tissue, which has evolved into a global
epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances …
epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances …
[HTML][HTML] Exploring the impact of obesity on skeletal muscle function in older age
Sarcopenia is of important clinical relevance for loss of independence in older adults. The
prevalence of obesity in combination with sarcopenia ('sarcopenic-obesity') is increasing at …
prevalence of obesity in combination with sarcopenia ('sarcopenic-obesity') is increasing at …
[HTML][HTML] Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity
Obesity, and associated metabolic syndrome, have been identified as primary risk factors for
the development of knee osteoarthritis (OA), representing nearly 60% of the OA patient …
the development of knee osteoarthritis (OA), representing nearly 60% of the OA patient …